Access Accelerated and the World Bank A strategic partnership for accelerated NCD progress
Since 2017, Access Accelerated and the World Bank Group have partnered under a shared vision for a better future. Together, we’ve cultivated a strong and continuously evolving long-term strategic partnership dedicated to supporting low- and middle-income countries (LMICs) and underserved communities with the financial and technical resources they need to expand access to quality, affordable care for noncommunicable diseases (NCDs).
Through this partnership, we’ve supported small grant projects in over 35 LMICs and generated a body of evidence that makes a persuasive case to countries for ongoing investment in quality NCD prevention, diagnosis, treatment, and care.
By connecting the World Bank’s multisectoral expertise and prominent position on the world stage with our global network of biopharmaceutical and life science companies, we’ve forged a partnership capable of making a significant impact on the prosperity of LMICs, the strength and resilience of healthcare systems, and the well-being of individuals and communities, today and in the future.
About the World Bank
The World Bank Group, made up of 189 member countries, is the world’s leading health financing agency, with priorities that include decreasing poverty and increasing shared prosperity, building human capital, and supporting countries in achieving universal health coverage. Since 1947, the World Bank has funded over 12,000 development projects around the world via traditional loans, interest-free credits, and grants.
Learn more
"At the heart of our collective efforts is our work with countries to enable better health and well-being for millions. Since 2017, the World Bank and Access Accelerated partnership has made a vital contribution to the countrylevel NCD agenda. The financing from the Access Accelerated partnership gave our operational teams access to additional flexible resources to support countries in innovative analytics and technical assistance to inform policy dialogue on NCD care integration through health systems strengthening programs. We look forward to continuing our collaborative efforts driven by the shared goal of improving health outcomes for all."
Dr. Monique Vledder Head of the Global Health, Nutrition and Population Department World Bank
Why we collaborate
NCDs cut across the main pillars of the World Bank’s health strategy: financial protection to prevent people from falling into poverty due to health spending, increasing quality health coverage for the poorest 40% of the population, and fostering a healthy society, including investments that reduce risk factors. In this way, the World Bank and Access Accelerated are united in our shared priorities, values, and vision for the future.
How we work
The World Bank Group brings wide-ranging multisectoral expertise and decades of experience funding successful initiatives in LMICs.
Access Accelerated unites biopharmaceutical and life science companies, leveraging the private sector’s unique reach and know-how to accelerate global progress on NCDs.
Together, we support needs-driven, multisectoral, and systems-oriented initiatives that create enabling policy environments and establish evidence that empowers countries to take on NCDs.
The partnership in action
Our work together has translated global commitments into national action, improved public-private sector engagement, catalyzed greater investment that includes national funds and World Bank-funded loans, enabled the scale-up of programs to new countries and regions, and helped countries strengthen their ability to address NCDs.
We focus our efforts in the following areas
1. Informing local and global health priorities to improve NCD response in LMICs
2. Accelerating public and private investment in NCD prevention, treatment, and care
3. Facilitating evidence-based decision-making with rigorous measurement and knowledge sharing
Our partnership with the World Bank continues to be very fruitful. Working together to address NCDs is an incredibly complex endeavor and demands not only flexibility but values and aims that are in total alignment with each other. With the World Bank, it’s a perfect fit. It has enabled us to make a significant difference for people living with NCDs.
Michael Fredrich, Lead Access to Medicine Non-Communicable Diseases, Bayer Pharmaceuticals and Chair, Access Accelerated
Terms of Use
IFPMA (“we”, “us”) owns and operates www.accessaccelerated.org (“the/our website”). Any person accessing and/or using the website (“the visitor/user”) agrees to the “Terms of Use”, containing the conditions, rules and other provisions with respect to the access and/or use of our website. If you have questions about the “Terms of Use”, please feel free to contact us at admin@ifpma.org.
CONTENT
General Use
The material contained on this website is for information only. The website is entitled to be served as an information resource for the internal and external stakeholders of the Access Accelerated initiative, including the general public. Third-Party Websites Links to other websites are provided solely as a convenience and therefore imply neither IFPMA’s responsibility for, nor its approval of the information contained in these websites.
Intellectual Property
Any use of information from the website should have an acknowledgement of Access Accelerated/Third-Party as a source respectively, citing the corresponding uniform resource locator (URL).
Logo and Name
The use of Access Accelerated's name and/or logo is prohibited without prior express authorization from IFPMA. The access and/or use of the website does not permit to copy, reproduce, modify, distribute or exploit Access Accelerated's name and/or logo except with the prior explicit permission.
Abuse and Violation
Any abuse or violations of the Terms of Use and/or Privacy Policy should be reported to secretariat@accessaccelerated.org.
DISCLAIMER
IFPMA renounces any liability or responsibility for any damages of any nature whatsoever resulting from the use of, inability to use, and/or reliance on the material and information contained on the Access Accelerated website. IFPMA makes no representations or warranties as to the completeness or accuracy of any of the information available on the website as well as does not provide any warranties regarding the security of the content of our website or any linked websites. IFPMA endeavours to make its best effort to keep the information accurate and updated on a regular basis, however this is not claimed to be exhaustive. IFPMA does not guarantee that the website is continuously available and error-free at all times.
Privacy Policy
IFPMA is committed to protecting the privacy and security of visitors to the Access Accelerated website. Outlined below is our online privacy policy for information collected through our website. If you have questions about these policies, please feel free to contact us at secretariat@ifpma.org.
Personal Information
We constantly analyse our website logs to improve the value of the Access Accelerated website. We do not use this analysis to record or track any personally identifiable information of visitors. If you are asked to provide personal information such as your name, e-mail or/and postal address when requesting information, providing feedback, registering to a newsletter, or using any other functions of the website, be assured that all such information is considered by IFPMA both private and secure. IFPMA does not share or sell your personal information to third parties. Under no circumstance will details be disclosed publicly, except in order to comply with any legal obligation. This policy reiterates that IFPMA fully appreciates the importance of online privacy and is committed to protecting your personal information.
Use of Cookies Files
The Access Accelerated website is enhanced by cookie files to personalize and customize the experience of our visitors and to support some necessary functions. IFPMA collects broad usage statistics using Google Analytics, to better understand how our visitors use our website, and to help us improve visitors’ experience. Such information includes the IP address (where available), browser type, and any additional information provided by a browser during the use of our website. The statistical data about our users’ browsing actions and patterns does not identify any individual. You may choose to accept or refuse cookies by modifying your browser preferences. If you wish to get notified when a cookies are set, this option should also be available in your browser settings. Please note that if you reject some or all cookies, your experience at this and other websites throughout the Internet may not be complete.
Payment Transactions
To enable IFPMA to process any order or registration to an event, a secure online payment system may be used to process payments using credit card details. IFPMA will not be collecting or storing credit card details in our system.
Third-Party Websites
Please be aware that other websites to which links may be provided, including social media, may collect visitor’s personally identifiable information when accessed. The information collection practices of other websites linked to IFPMA’s website are not covered by this Privacy Policy.
Cookie Policy
Some of our web pages utilise “cookies”. A “cookie” is a small text file that may be used, for example, to collect information about web site activity. Some cookies and other technologies may serve to recall Personal Information previously indicated by a web user. Most browsers allow you to control cookies, including whether or not to accept them and how to remove them.
Some cookies are necessary for the operation of our website, if you choose to block them some aspects of the site may not work for you. Non necessary cookies are only set when you have given your explicit consent to their use. Such cookies included those set by our statistics package Google Analytics.
We are committed to privacy and support current industry initiatives to preserve individual privacy rights on the Internet. Protecting your privacy on-line is an evolving area and this website will constantly evolve to meet these demands.
